Interleukin-1 beta (IL-1) does not reduce the diabetes incidence in diabetes-prone BB rats.
The cytokine interleukin 1 beta (IL-1) has been implicated as a pathogenetic factor in the initial events leading to insulin-dependent diabetes mellitus. Previous studies investigating the impact of IL-1 on diabetes incidence in spontaneously diabetic rodent models have been conflicting. IL-1 induces anorexia and previous studies are hampered by the lack of pair-fed controls to the IL-1 treated animals. We report that daily injections of 4.0 micrograms/kg/day of recombinant human IL-1 (rhIL-1) for 13 weeks from 25-30 days of age did not alter the incidence of diabetes in the diabetes-prone (DP) BB rats (75%) when compared to pair-fed, vehicle treated controls (55%, p = 0.18), or to unhandled DP BB rats (80%, p = 0.71). However, IL-1 induced significantly higher blood glucose concentrations in the prediabetic period (p < 0.00005) and at diabetes onset (p < 0.00005) in the DP BB rats and caused episodes of blood glucose concentrations > 11 mmol/l in the prediabetic period in 11/20 DP BB rats compared to 4/27 diabetes-resistant (DR) BB rats and 4/28 Wistar Furth (WF) rats (both p < 0.004), compared to DP BB). Further, rhIL-1 induced fever in 11 weeks in the DP BB rats compared to 3 weeks in the DR BB and 6 weeks in the WF rats. Using high performance size exclusion chromatography specific anti-rhIL-1-antibodies were demonstrated in DR BB and WF, but not in DP BB rats. These antibodies neutralized the inhibitory effect of rhIL-1 on insulin secretion from isolated islets of Langerhans in vitro. The reduced pyrogenic and endocrine effect of rhIL-1 in the DR BB and WF rats compared to the DP BB rats could be explained by the impaired ability of the DP BB rats to produce anti-rhIL-1-antibodies. In conclusion, administration of rhIL-1 modulated the prediabetic period, and produced higher blood glucose concentrations at diagnosis, but did not change the diabetes incidence in DP BB rats. The results are not in conflict with the hypothesis that IL-1 is a pathogenetic factor in IDDM, caused by high local concentrations of rat IL-1 in the islets during early insulitis. The results also show the necessity of pair-feeding of the control group to the rhIL-1 group when interpreting data from experiments investigating rhIL-1 effects on diabetes development in animal models.
Reimers
J I
JI
Steno Diabetes Center, Gentofte, Denmark.
Mørch
L
L
Markholst
H
H
Wogensen
L D
LD
Andersen
H U
HU
Mandrup-Poulsen
T
T
Nerup
J
J
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001831:Body Temperature / Q000276:immunology; D001835:Body Weight / Q000276:immunology; D002352:Carrier Proteins / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000276:immunology* / Q000503:physiopathology; D004435:Eating / Q000276:immunology; D005260:Female; D005434:Flow Cytometry; D006728:Hormones / Q000097:blood; D007375:Interleukin-1 / Q000097:blood / Q000502:physiology*; D007958:Leukocyte Count; D008297:Male; D051381:Rats; D011913:Rats, Inbred BB; D011920:Rats, Inbred WF; D017472:Receptors, Interleukin-1; D011994:Recombinant Proteins / Q000494:pharmacology
D001786:Blood Glucose; D002352:Carrier Proteins; D006728:Hormones; D007375:Interleukin-1; D017472:Receptors, Interleukin-1; D011994:Recombinant Proteins